KRN Krones AG

DGAP-News: Krones AG: Krones generates high order intake in first half of 2021 and improves profitability

DGAP-News: Krones AG / Key word(s): Half Year Results
Krones AG: Krones generates high order intake in first half of 2021 and improves profitability

03.08.2021 / 07:30
The issuer is solely responsible for the content of this announcement.


3 August 2021

Krones generates high order intake in first half of 2021 and improves profitability

Krones, the leading manufacturer of filling and packaging technology, today published its report for the first half of 2021. Following a successful start to the 2021 financial year, business continued to develop dynamically between April and June. Overall, Krones' markets have so far recovered faster than expected from the pandemic-related downturn.

Strong demand for Krones products and services

Order intake increased by 58.3% relative to the second quarter of 2020, to €975.5 million in the second quarter of 2021. In the first six months of 2021, the contract value of orders went up by 40.3% year on year to €2,044.3 million. The order intake in the first half of 2021 was higher than the prior year in all of Krones' sales regions. As of 30 June 2021, the company had an order backlog totalling €1,535.5 million. This marks a significant increase in the order backlog compared both with the beginning of 2021 (up 26.8%) and with a year earlier (up 35.5%).

It should be noted with regard to the revenue performance that revenue in the first quarter of 2020 was hardly affected by Covid-19. Revenue in the first half of 2021 consequently showed only a slight year-on-year increase of 1.3% to €1,720.1 million. In the second quarter of 2021, on the other hand, revenue showed strong year-on-year growth to some €845.5 million, marking a rise of around 11.7% on the prior-year quarter.

Krones significantly improves profitability and free cash flow

Despite rising costs, notably of materials and freight, Krones' profitability improved significantly in the period January to June 2021. This was due most of all to structural measures that the company has launched and already implemented. Earnings before interest, taxes, depreciation and amortisation went up 16.2% year on year in the first half of 2021, from €118.5 million to €137.7 million. The EBITDA margin increased to 8.0% (previous year: 7.0%). EBITDA includes a Covid-19 bonus for employees totalling around €5 million paid out by Krones in the second quarter. Nevertheless, EBITDA in the second quarter of 2021, at €61.2 million, was more than twice as high as in the previous year (EUR 29.0 million).

Krones' earnings before taxes (EBT) increased significantly year on year in the first half of 2021, from €31.8 million to €75.7 million. It should be noted in this connection that EBT in the previous year was affected by €13.6 million in goodwill impairments. In total, Krones generated consolidated net income of €56.9 million from January to June 2021 (previous year: €21.5 million). Earnings per share consequently went up from €0.68 in the previous year to €1.80.

Krones significantly improved free cash flow in the first six months of 2021 by €100.2 million to €35.4 million (previous year: €-64.8 million). The company thus consolidated its strong finances. Net cash and cash equivalents, meaning cash and cash equivalents less bank debt, increased to €203.7 million at the end of June 2021 (previous year: €-77.9 million). In addition, Krones had around €1.05 billion in unused lines of credit as of 30 June 2021. Average working capital over the past four quarters increased slightly as a percentage of revenue to 28.1% in the first six months of 2021 (previous year: 27.6%).

Krones remains optimistic for 2021 and has raised its guidance

For the second half of 2021, the company expects demand to stay strong and production capacity utilisation to remain stable. Based on the good figures for the first half year and the positive outlook for the third and fourth quarters of 2021, Krones already raised its full-year guidance for 2021 on publication of the preliminary half-year results on 23 July. For the Krones Group, the Executive Board expects full-year revenue growth of 7% to 9% in 2021 (previously 2.5% to 3.5%). Krones anticipates an EBITDA margin of 7% to 8% (previously 6.5% to 7.5%). For the third performance target, working capital to revenue, the guidance remains unchanged at 26% to 27%.

The guidance for 2021 is subject to the assumption that there will be no severe impacts from the Covid-19 pandemic, problems in supply chains or other general economic impacts.

Krones has published the complete Interim Report for the first half of 2021 online at


Contact:
Olaf Scholz
Head of Investor Relations, Krones AG
Tel.: 9
E-Mail:



03.08.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Krones AG
Böhmerwaldstraße 5
93073 Neutraubling
Germany
Phone: +49 (0)9401 701169
Fax: +49 (0)9401 709 1 1169
E-mail:
Internet:
ISIN: DE0006335003
WKN: 633500
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1223483

 
End of News DGAP News Service

1223483  03.08.2021 

fncls.ssp?fn=show_t_gif&application_id=1223483&application_name=news&site_id=research_pool
EN
03/08/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Krones AG

Krones AG: 1 director

A director at Krones AG sold 4,200 shares at 142.347EUR and the significance rating of the trade was 96/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

Bruno Cavalier ... (+4)
  • Bruno Cavalier
  • Hela Zarrouk
  • Oliver Metzger
  • Roy Külter
CON CONTINENTAL AKTIENGESELLSCHAFT
FME FRESENIUS MEDICAL CARE AG
LUFTHANSA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
FRA FRAPORT AG
TKA THYSSENKRUPP AG
WCH WACKER CHEMIE AG
DGE DIAGEO PLC
DB1 DEUTSCHE BOERSE AG
RNO RENAULT SA
ADS ADIDAS AG
G1A GEA GROUP AG
MC LVMH MOET HENNESSY LOUIS VUITTON SE
MTX MTU AERO ENGINES AG
CBK COMMERZBANK AG
RI PERNOD RICARD SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DAI DAIMLER AG
RCO REMY COINTREAU SA
HNR1 HANNOVER RUECK SE
GBF BILFINGER SE
UTDI UNITED INTERNET AG
RHM RHEINMETALL AG
ALV ALLIANZ SE
LXS LANXESS AG
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
KCO KLOECKNER & CO SE
BRBY BURBERRY GROUP PLC
MRK MERCK KGAA
KER KERING SA
VNA VONOVIA SE
EOAN E.ON SE
BOSS HUGO BOSS AG
SDF K+S AG
ZAL ZALANDO SE
G24 SCOUT24 AG
BAS BASF SE
RWE RWE AG
HEI HEIDELBERGCEMENT AG
BAYN BAYER AG
VOW3 VOLKSWAGEN AG PREF
HEN3 HENKEL AG & CO. KGAA PREF
DTE DEUTSCHE TELEKOM AG
TLX TALANX AG
SY1 SYMRISE AG
01913 PRADA S.P.A.
COFB COFINIMMO SA
FIE FIELMANN AG
DEZ DEUTZ AG
AIXA AIXTRON SE
NDA AURUBIS AG
KRN KRONES AG
NEM NEMETSCHEK SE
AED AEDIFICA SA
LEG LEG IMMOBILIEN AG
KGX KION GROUP AG
MONC MONCLER SPA
CPINV CARE PROPERTY INVEST SA
BNR BRENNTAG SE
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
RACE FERRARI NV
JUN3 JUNGHEINRICH AG PREF
FTG111 FLATEXDEGIRO AG
SIE SIEMENS AG
DUE DURR AG
SHL SIEMENS HEALTHINEERS AG
S92 SMA SOLAR TECHNOLOGY AG
JEN JENOPTIK AG
KBX KNORR-BREMSE AG
HAG HENSOLDT AG
CPR DAVIDE CAMPARI-MILANO N.V.
ENR SIEMENS ENERGY AG
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
FPE3 FUCHS PETROLUB SE
BEAN BELIMO HOLDING AG
DTG DAIMLER TRUCK
ZGN ERMENEGILDO ZEGNA NV
STM STABILUS SE
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
TUI TUI AG
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
R3NK RENK GROUP AG
QGEN QIAGEN N.V.
PFSE PFISTERER HOLDING SE
SHA SCHAEFFLER AG
TKMS TKMS AG & CO. KGAA

ResearchPool Subscriptions

Get the most out of your insights

Get in touch